
|Articles|April 9, 2015
Oncology Drug Snapshot: Axitinib (Inlyta)
Author(s)Cancer Network Editors
This oncology drug snapshot takes a look at axitinib (Inlyta) for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
Advertisement
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – November 5, 2025
2
Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
3
What Were the Most Significant Inflection Points or Breakthroughs in Cell and Gene Therapy?
4
Quarter Century Update: The Impact of Artificial Intelligence
5










































